Dianthus Therapeutics Inc... (DNTH)
undefined
undefined%
At close: undefined
23.81
0.21%
After-hours Dec 13, 2024, 04:15 PM EST

Cashflow (Annual)

Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
Year FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16
Net Income -43.55M -28.48M -13.11M -74.94M -76.77M -57.52M -35.49M -9.43M
Depreciation & Amortization 355.00K 147.00K 2.02M 1.98M 1.84M 875.00K 376.00K 6.00K
Stock-Based Compensation 2.90M 1.52M 63.00K - - - 2.26M 662.00K
Other Working Capital -959.00K -3.93M -1.78M -2.13M 8.69M 1.48M 2.44M 590.00K
Other Non-Cash Items -762.00K -606.00K 803.00K 13.13M 12.53M 10.02M 13.41M 306.00K
Deferred Income Tax -661.00K - -2.82M -12.95M -13.54M - - -
Change in Working Capital 4.86M -1.65M 3.14M -1.19M 8.83M 3.98M 1.32M 1.60M
Operating Cash Flow -36.86M -29.07M -9.90M -64.02M -57.10M -41.89M -22.26M -6.53M
Capital Expenditures -110.00K -139.00K -33.00K -400.00K -3.06M -7.67M -2.20M -139.00K
Acquisitions - -175.00K -1.23M - - 12.00K - -
Purchase of Investments -57.42M -61.68M -45.31M -95.73M -144.37M -84.04M - -
Sales Maturities Of Investments 77.78M 2.00M 90.00M 85.50M 148.96M - - -
Other Investing Acitivies - 175.00K -43.46M - - 12.00K -135.00K -
Investing Cash Flow 20.25M -59.82M -33.00K -10.63M 1.53M -91.70M -2.20M -139.00K
Debt Repayment - - - - - - - 6.50M
Common Stock Repurchased - - - - - -88.00K -213.00K -107.00K
Dividend Paid - - - - - - - -
Other Financial Acitivies 61.57M 96.68M -59.69M - - - - -
Financial Cash Flow 133.57M 96.68M 14.91M 67.74M 62.30M 142.15M 71.49M 10.71M
Net Cash Flow 116.97M 7.79M 4.97M -6.92M 6.73M 6.78M 47.02M 4.04M
Free Cash Flow -36.97M -29.21M -9.94M -64.42M -60.16M -49.56M -24.46M -6.67M